SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RevMikeB who wrote (23316)7/17/1998 6:16:00 PM
From: Andreas Helke  Read Replies (1) of 32384
 
If Ligand got cash outright instead of cash in exchange to shares that would be a far smaller amount of money than what they can get with a stock sale. To raise the missing money the same shares that are not sold to a pharma company at a premium to the market price would have to be sold to the general public at a discount to the market price in a secondary offering. The dilution would probably be even higher that way and we would get a even more bumpy stock chart with extra dips due to repeated secondary offerings.

Andreas
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext